Position in XWEL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$68
-$7 QoQ
Shares Held
66
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in XWEL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Allworth Financial LP holds $27,687,254 across 34 Diagnostics & Research names. XWEL ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,334 | $12,200,093 | |
| 2 | A |
Agilent Technologies, Inc.
|
20,420 | $2,712,388 | |
| 3 | DHR |
Danaher Corp /De/
|
11,176 | $2,128,804 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
3,894 | $2,062,223 | |
| 5 | LH |
Labcorp Holdings Inc.
|
5,963 | $1,669,640 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
2,531 | $1,332,419 | |
| 7 | NTRA |
Natera, Inc.
|
3,878 | $1,052,683 | |
| 8 | ILMN |
Illumina, Inc.
|
5,976 | $1,050,760 |
All Filings in XWEL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $68 | 66 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $75 | 66 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $30 | 66 | Shares | Sole | 2026-02-05 | |
| 2025-03-31 | $15 | 15 | Shares | Sole | 2025-04-30 | |
| 2021-12-31 | $4,040 | 2,000 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $4,410 | 3,000 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $4,620 | 3,000 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $5,521 | 3,001 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,571 | 3,001 | Shares | Sole | 2021-01-26 | |
| No filing history on record for this holder in this stock. | ||||||